Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade

Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade

The present study aimed to investigate the potential of basal cell-free fluorometric DNA (cfDNA) quantification as a prognostic biomarker in advanced non-small cell lung cancer (NSCLC) patients treated with an Immune Checkpoint Blockade (ICB). A discovery and validation cohort of 61 and 31 advanced...

Full description

Bibliographic Details
Main Authors: Javier Oliver, Juan Luis Onieva, María Garrido-Barros, Manuel Cobo-Dols, Beatriz Martínez-Gálvez, Ana Isabel García-Pelícano, Jaime Dubbelman, José Carlos Benítez, Juan Zafra Martín, Alejandra Cantero, Elisabeth Pérez-Ruiz, Antonio Rueda-Domínguez, Isabel Barragán
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Cancers
Subjects:
cfDNA
immunotherapy
NSCLC
prognosis
Online Access:https://www.mdpi.com/2072-6694/15/13/3357

Internet

https://www.mdpi.com/2072-6694/15/13/3357

Similar Items